Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
03/2005
03/23/2005CN1599741A Thioether substituted imidazoquinolines
03/23/2005CN1599740A Amide substituted imidazopyridines
03/23/2005CN1599739A Sulfonamido substituted imidazopyridines
03/23/2005CN1599738A Urea substituted imidazopyridines
03/23/2005CN1599737A Ring fused pyrazole derivatives
03/23/2005CN1599734A 3, 4-di-substituted maleimide compounds as CXC-chemokine receptor antagonists
03/23/2005CN1599621A Use of collagenase to facilitate guide wire crossing in total arterial occlusions
03/23/2005CN1599620A Process of preparation of formulations of the peptide angiotensin-(1-7) and its analogues, agonistic and antagonists using cyclodextrins, lipossomes and biodegradable polymers and/or mixtures and prod
03/23/2005CN1599618A Stabilization of hypoxia inducible factor (HIF) alpha
03/23/2005CN1599616A Storage-stable human fibrinogen solutions
03/23/2005CN1599607A Carbinols for the treatment of neuropathic dysfunction
03/23/2005CN1596974A Haemopoietin nasal administration medicnment and its preparation method and use
03/23/2005CN1596945A Chinese herbal plant medicinal oil
03/23/2005CN1596910A Human platelet substitute and its preparation method
03/23/2005CN1596907A Use of bamboo leaf flavone in preparation of medicine or health-care food for preventing or treating thrombus disease or blood deficiency disease
03/23/2005CN1596900A Rusco saponin element and application of its saponin in preparation of medicine preventing and treating embolus disease
03/23/2005CN1596889A Vitamin E emulsion and its freeze-dried emulsion compound and preparation method
03/23/2005CN1596885A Propyl gallate freeze-dried powder-injection and its preparation method
03/23/2005CN1596882A Vitamin K1 emulsion and its freeze-dried emulsion and preparation method
03/23/2005CN1194014C Coupled cmpound of hematopoietin and polyethylene glycol
03/23/2005CN1194009C Anticoagulant protein mediated by anticoagulant protein of human placenta
03/23/2005CN1194007C Separation, synthesis and application in medicine for P6A'S metabolic product
03/23/2005CN1193746C Substituted nitrobenzene derimative for medicine and other use
03/22/2005US6869973 Nitrosated and nitrosylated taxanes, compositions and methods of use
03/22/2005US6869952 Such as 4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-5-methyl-pyrrolo(2,1-f)(1,2,4)triazin-6-ol; for treament of cancer
03/22/2005US6869945 Antihistamines; respiratory system disorders; antiinflammatory agents
03/22/2005US6869605 Anticarcinogenic agents
03/17/2005WO2005023308A1 Formulations of vitamin k-dependent polypeptides and sulfoalkyl ether cycloextrins
03/17/2005WO2005023235A1 Benzyl alcohol derivatives or salts thereof
03/17/2005WO2005023225A1 Cilostazol adsorbate
03/17/2005WO2005023218A1 Emulsion of perfluororganic combination with a function of gastransport
03/17/2005WO2005016455A3 Antibodies against factor viii with modified glycosylation in the variable region
03/17/2005WO2004082708A3 Liquid, aqueous, pharmaceutical compositions of factor vii polypeptides
03/17/2005WO2004043486A8 An acqueous pharmaceutical formulation comprising the thrombin inhibitor melagatran and use of the formulation in the manufacture of a medicament for use by nasal administration in treating thromboembolism
03/17/2005WO2002050028A8 Substituted benzoindoles as spla2 inhibitors
03/17/2005US20050059726 For treating thrombosis and factor xa-related cardiovascular and neurodegenerative diseases; 6-Chloro-N-{(3S)-1-[3-fluoro-2'-(methylsulfonyl)-1,1'-biphenyl-4-yl]-2-oxopyrrolidin-3-yl}naphthalene-2-sulfonamide for example
03/17/2005US20050059700 Reacting compunds such as 6-methyl-12-oxa-tricyclo[8.2.1.0]trideca-2,4,6-trien-11-ol with compounds such as 4-(2,6-dichloro-phenyl)-piperidine to produce (+-)-cis-1-methyl-7-[[4-(2,6-dichloro-phenyl)piperidin-1-yl)]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol
03/17/2005US20050059686 Pyrrolopyrimidines as phosphodiesterase vII inhibitors
03/17/2005US20050059683 A1 adenosine receptor antagonists
03/17/2005US20050059665 Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use
03/17/2005US20050059609 New alpha crystalline form of perindopril tert-butylamine salt
03/17/2005US20050059600 Chimeric natriuretic peptides
03/17/2005US20050059132 Variant blood coagulation factor for use as tool in treatment of thrombosis
03/17/2005US20050059093 Method for detecting modulators of Notch signalling
03/17/2005US20050059081 Dipeptidyl peptidase IV (DPPIV); homology with family of prolyl oligopeptidases; drug screening for enzyme inhibitors for DPPIV which could treat reproductive, inflammatory and metabolic disorders; antibodies for therapeutic or diagnostic use; host cells
03/17/2005US20050058648 Antibodies against caspase-8, their preparation and use
03/17/2005US20050058636 Medicament against thrombotic diseases
03/17/2005CA2741575A1 Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
03/17/2005CA2741412A1 Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
03/16/2005EP1514867A2 Substituted phenyl derivatives, their preparation and use
03/16/2005EP1514555A1 Polyherbal formulation for hepatic and splenic disorders
03/16/2005EP1513880A1 Epimerized derivatives of k5 polysaccharide with a very high degree of sulfation
03/16/2005EP1513864A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
03/16/2005EP1513837A1 Thiazole derivatives as phosphodiesterase iv inhibitors
03/16/2005EP1513830A1 Bisindolyl-maleimid derivatives as kinase inhibitors
03/16/2005EP1513827A1 1,3,5-triazine derivatives as ligands for human adenosine-a3 receptors
03/16/2005EP1513810A1 4-(aryl or heteroaryl) -2-butylamine derivatives and their use as glucocorticoid ligans
03/16/2005EP1513807A1 Pharmaceutical combination
03/16/2005EP1513806A1 New salts
03/16/2005EP1513588A2 Use of new etonogestrel esters
03/16/2005EP1513554A1 Cd16a binding proteins and use for the treatment of immune disorders
03/16/2005EP1513548A2 Method for reducing obstructive hydrocephalus
03/16/2005EP1513524A2 Ether substituted imidazopyridines
03/16/2005EP1513522A2 Methods of treating conditions associated with an edg receptor
03/16/2005EP1513520A2 Substituted pyrrolines as kinase inhibitors
03/16/2005EP1513496A1 Immediate release pharmaceutical formulation
03/16/2005EP1513495A1 Modified release pharmaceutical formulation
03/16/2005EP1355894B1 Amidinophenylalanine derivatives as thrombin inhibitors
03/16/2005EP1311476B1 Aza-amino acid derivatives (factor x a?-inhibitors 15)
03/16/2005EP1233959B1 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents
03/16/2005EP1037923B1 Method for preparing by filtration a virally secure factor viii solution
03/16/2005EP0869966B1 Prodrugs of thrombin inhibitors
03/16/2005EP0721783B1 Preventive and remedy for diseases caused by fibrinoid or thrombus formation in the lung
03/16/2005CN1596310A Method for producing a recombinant polypeptide
03/16/2005CN1596255A Chemokine receptor binding heterocyclic compounds with enhanced efficacy
03/16/2005CN1596253A Spiro-hydantoin compounds useful as anti-inflammatory agents
03/16/2005CN1596127A Controlled release drug delivery composition comprising polycationic polymer and negatively charged pharmacologically active compound
03/16/2005CN1596125A Pharmaceutical composition comprising factor vii polypeptides and factor v polypeptides
03/16/2005CN1596122A Pharmaceutical composition comprising factor vii polypeptides and pai-1 polypeptides
03/16/2005CN1596115A Treatment of hyperproliferative diseases using active vitamin D analogues
03/16/2005CN1596114A Substituted 1, 4-benzodiazepines and uses thereof for the treatment of cancer
03/16/2005CN1594360A Red cashew nut legumin and its preparation and use
03/16/2005CN1594319A Process for extracting ginkgolide, ginkgolide injection and process for preparing same
03/16/2005CN1594270A Novel L-2-(alpha-hydroxy pentyl)benzoate and its preparation method and use
03/16/2005CN1593655A Leading thrombolysis agent, preparation method and application thereof
03/16/2005CN1593647A Nutrient and healthy capsule of active ass hide
03/16/2005CN1593642A Liver essence and blood nourishing medicinal powder and its preparation
03/16/2005CN1593634A Blood nourishing, brain refreshing orally disintegrating tablet and its preparation process
03/16/2005CN1593633A Orally disintegrating tablet for dredging vascular thrombus and its preparation process
03/16/2005CN1593620A Detoxification Chinese medicine
03/16/2005CN1593618A Chinese medicinal powder with gall, giant knotweed, hyacinth bletilla and bornel
03/16/2005CN1593615A Orally disintegrating tablet of 'Mailuo Ning' and its preparation
03/16/2005CN1593608A Medicinal powder with donkey hide and its preparation process
03/16/2005CN1593594A Chinese traditional medicinal composition and its preparation process and usage
03/16/2005CN1593552A Multifunctional externally applied botanical liquid
03/16/2005CN1593527A Dispersible tablet of 'Duyiwei' and its preparing method
03/16/2005CN1593506A Bone marrow benefiting capsule for treating anemia
03/16/2005CN1593500A Kidney benefiting, Chong collateral reinforcing and menstruation regulating hemostat
03/16/2005CN1593483A Medicine for treating leukopenia and its preparing process
03/16/2005CN1593436A Application of ursane type triterpenoid saponin in the preparing process of leucocyte and/or platelet increasing medicine
1 ... 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 ... 671